Fundraising Fox

Casey Tansey

Investor

General Partner at US Venture Partners · Board director at HeartFlow Holding · Board director at ShiraTronics · Board director at Shoulder Innovations

Menlo Park, California

Writes $2M – $10M checks · typically $6M

Find your path to Casey

50 people in our graph share verified history with Casey — schools, employers, funds. One of them is your warm intro.

Chris RustunlockedCasey: together at US Venture Partners
×2Casey: together at Neochord
×4Casey: together at ShiraTronics
×2Casey: together at HeartFlow

About

Casey Tansey joined USVP as a general partner in 2005, bringing over 25 years of medical device entrepreneurial and operating experience. He previously served as CEO and President of Epicor Medical and Heartport, and focuses on minimally invasive medical technologies in cardiovascular, orthopedics, spinal care and neurology.

Contact· self-published, not guessed

Invests in

Digital HealthHealthtechMedical Devices

Board director at HeartFlow Holding

Intro paths

In turn, Casey can intro founders to HeartFlow Holding's investors below.

Co-founders at HeartFlow Holding

CT
Charles TaylorDirector

Board director at ShiraTronics

Intro paths

In turn, Casey can intro founders to ShiraTronics's investors below.

Board director at Shoulder Innovations

Intro paths

In turn, Casey can intro founders to Shoulder Innovations's investors below.

Deals · 13

Cagent VascularBoard seat

via US Venture Partners · filed Jun 2026 · $41M raise

press ↗

IantrekBoard seat

via US Venture Partners · filed Aug 2025 · $42M raise

Neuros MedicalBoard seat

via US Venture Partners · filed Aug 2025 · $65M raise

HeartFlow HoldingBoard seat

via US Venture Partners · filed Apr 2025 · $50M raise

Shoulder InnovationsBoard seat

via US Venture Partners · filed Mar 2025 · $40.1M raise

MicroTransponderBoard seat

via US Venture Partners · filed Mar 2025 · $65M raise

NeochordBoard seat

via US Venture Partners · filed Mar 2025 · $2.1M raise

LuminopiaBoard seat

via US Venture Partners · filed Jun 2023 · $16.8M raise

HeartFlowBoard seat

via US Venture Partners · filed Jun 2019 · $100M raise

SentreHeartBoard seat

via US Venture Partners · filed Oct 2016 · $35M raise

ApniCureBoard seat

via US Venture Partners · filed Mar 2016 · $17.4M raise

Intuity MedicalBoard seat

via US Venture Partners · filed Jul 2015 · $2M raise

Reshape MedicalBoard seat

via US Venture Partners · filed Mar 2015 · $8.8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: the firm's website · SEC Form D filings.

Colleagues at US Venture Partners

Network8

Investors connected to Casey in public investor directories — a warm-intro map.

Frequently asked questions

Who is Casey Tansey?
Casey Tansey joined USVP as a general partner in 2005, bringing over 25 years of medical device entrepreneurial and operating experience. He previously served as CEO and President of Epicor Medical and Heartport, and focuses on minimally invasive medical technologies in cardiovascular, orthopedics, spinal care and neurology.
Where does Casey Tansey work?
Casey Tansey is General Partner at US Venture Partners and Board director at HeartFlow Holding and Board director at ShiraTronics and Board director at Shoulder Innovations.
What does Casey Tansey invest in?
Casey Tansey invests in Digital Health, Healthtech, Medical Devices.
What check size does Casey Tansey write?
Casey Tansey typically writes checks of $2M – $10M.
What boards does Casey Tansey sit on?
Casey Tansey holds tracked board seats at ApniCure, AtheroMed, Cagent Vascular, Cagent Vascular, Contego Medical, Dstillery, HeartFlow, HeartFlow, HeartFlow Holding, Highlife Medical.
What companies has Casey Tansey invested in?
Investments tracked here include Epicor Medical.
Does Casey Tansey lead rounds?
Yes — Casey Tansey has led 1 tracked investment.